Scholars Central

Conference abstractPublished 13 Oct 2016

Type 1 Diabetes: Prediction and progression

Authors: K M Gillespie

University of Cambridge, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Multiple islet autoimmunity increases risk of diabetes but not all individuals positive for two or more islet autoantibodies progress to disease within a decade. The SNAIL study seeks to harmonize data from longitudinal studies to identify the characteristics of slow progression to type-1 diabetes. Samples from 125 individuals with multiple islet autoantibodies (IAA, GADA, IA-2A and ZnT8A) for more than 10 years without progression were available from four studies (Bart-Oxford (BOX), UK; BABYDIAB, Germany; DAISY and Pittsburgh Diabetes, USA). Individuals enrolled in BOX provided “Rapid Progressor” (diagnosed <age 5 years) and at diagnosis samples. Intermediate HLA-Class II risk was more frequent in slow (61%) than Rapid Progressors (49%) with a reciprocal reduction in high risk genotypes (24% vs. 48%; pCorr=0.005) but none carried protective HLA DQ6. Slow Progressors carried fewer HLA-Class I B risk alleles (48%) than Rapid Progressors (86%; pCorr<0.001). Of 35 Slow Progressors with longitudinal data available, only 13 (37%) retained multiple autoantibodies after 10 years (p<0.001). A reduction in positivity for IAA and GADA was observed (p<0.001 and p=0.016 respectively) and in levels of GADA, IA-2A and ZnT8A even when autoantibody positive status was maintained (p<0.05 for all). In addition, Slow Progressors had lower levels of IA-2AIgG subclasses than individuals sampled close to diagnosis (p<0.05). Multiple autoantibody positivity is not maintained in some Slow Progressors suggesting regulation of the autoimmune response. Continued immuno-phenotyping of these individuals is required to elucidate the mechanisms underlying a decreased humoral response and delayed progression.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “K M Gillespie”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels